Simple Summary Nearly all breast cancer patients survive for more than five years when the
tumor is found early and in the localized stage. Regular clinical breast examinations …

In the UK, the National Institute for Health and Care Excellence (NICE) recommends that
women at moderate or high risk of breast cancer be offered risk-reducing medication and …

Background Nasopharyngeal carcinoma (NPC) is closely associated with genetic factors
and Epstein-Barr virus infection, showing strong familial aggregation. Individuals with a …

Purpose The benefit of using individual risk prediction tools to identify high-risk individuals
for breast cancer (BC) screening is uncertain, despite the personalized approach of risk …

Background Breast cancer is a widespread disease in women worldwide. Aim We aimed to
explore the global epidemiological trends of female breast cancer (FBC) between 1990 and …

Breast cancer (BC) is a major malignant tumor in females and the incidence rate of BC has
increased worldwide in recent years. N6-methyladenosine (m6A) is a methylation …

Background: To evaluate the utility of polygenic risk scores (PRSs) in identifying high-risk
individuals, different publicly available PRSs for breast (n= 85), prostate (n= 37), colorectal …

Breast cancer (BC) remains the most common cause of death in women worldwide, but
advances in science have allowed earlier diagnosis and more comprehensive treatment …

Simple Summary Personalized breast cancer screening has the potential to improve the
accuracy and effectiveness of breast cancer screening by tailoring the screening protocol to …

A breast cancer risk assessment tool for Asian populations, incorporating Polygenic Risk
Score and Gail Model algorithm, has been established and validated. However, effective …